2023 UEM Edgenta Annual Report

Section 8 UEM Edgenta Berhad FINANCIAL STATEMENTS 326 NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 19. INVESTMENT IN ASSOCIATES (CONTD.) Summarised financial information of Biomedix Solutions Sdn. Bhd. (“Biomedix”), One Medicare Sdn. Bhd. (“One Medicare”) and Sedafiat Sdn. Bhd. (“Sedafiat”), that are material associates of the Group are set out below. The summarised financial information represents the amounts in the MFRS financial statements of the associates and not the Group’s share of those amounts. (i) Summarised statements of financial position Biomedix One Medicare Sedafiat 2023 RM’000 2022 RM’000 2023 RM’000 2022 RM’000 2023 RM’000 2022 RM’000 Non-current assets 1,058 1,321 7,516 10,301 18,619 20,431 Current assets 76,780 78,718 135,743 139,696 112,174 106,664 Total assets 77,838 80,039 143,259 149,997 130,793 127,095 Non-current liabilities 4,586 9,034 2,984 14,012 3,778 467 Current liabilities 6,364 5,905 105,164 101,564 59,502 58,656 Total liabilities 10,950 14,939 108,148 115,576 63,280 59,123 Net assets 66,888 65,100 35,111 34,421 67,513 67,972

RkJQdWJsaXNoZXIy NDgzMzc=